Uptake rates of novel therapies and survival among privately insured versus publicly insured patients with colorectal cancer in Germany
Lina Jansen*
, Daniel Boakye
, Elizabeth Alwers
, Prudence R. Carr
, Christoph Reissfelder
, Martin Schneider
, Uwe M. Martens
, Jenny Chang-Claude
, Michael Hoffmeister
, Hermann Brenner
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
21Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Uptake rates of novel therapies and survival among privately insured versus publicly insured patients with colorectal cancer in Germany'. Together they form a unique fingerprint.